Skip to main content
. 2021 Oct 13;12:738788. doi: 10.3389/fimmu.2021.738788

Figure 1.

Figure 1

(A) Serum rituximab (RTX) levels at month-3 (M3) according to clinical status at month-6 (M6). (B) Serum rituximab (RTX) levels at month-3 (M3) according to clinical status at month-12 (M12). (C) Time from initiation of rituximab treatment to remission of nephrotic syndrome according to serum rituximab levels at month-3. M3, month-3 after rituximab injection; M6, month-6 after rituximab injection; M12, month-12 after rituximab injection; RTX, rituximab; UP, 24-hour urinary protein excretion.